Drug Discovery and the Market Today Part 3: The Focus on Solubility

Dr. David Elder is the Externalization Director for GlaxoSmithKline. Here, he talks exclusively to Pharma IQ on his perspective across the industry, including CROs, regulations, and strategising for efficiency..


To continue reading this story

Learn More   Existing Users